C07D 471/20
Spiro-condensed systems
C07D471/20 (Spiro-condensed systems) appears on 255 US grants and 360 published applications in this corpus.
Search patents in C07D- Granted patents
- 255
- Published applications
- 360
- Assignees
- 184
- Inventors
- 1,214
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 4 | 0 |
| 1989 | 3 | 0 |
| 1990 | 2 | 0 |
| 1991 | 4 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 3 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 1 |
| 2004 | 0 | 3 |
| 2005 | 2 | 8 |
| 2006 | 4 | 2 |
| 2007 | 3 | 7 |
| 2008 | 2 | 5 |
| 2009 | 4 | 8 |
| 2010 | 4 | 13 |
| 2011 | 7 | 21 |
| 2012 | 9 | 20 |
| 2013 | 12 | 9 |
| 2014 | 15 | 16 |
| 2015 | 18 | 31 |
| 2016 | 23 | 18 |
| 2017 | 22 | 19 |
| 2018 | 14 | 20 |
| 2019 | 14 | 23 |
| 2020 | 12 | 11 |
| 2021 | 15 | 17 |
| 2022 | 11 | 19 |
| 2023 | 6 | 23 |
| 2024 | 12 | 21 |
| 2025 | 11 | 25 |
| 2026 | 9 | 20 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Spirotricycle RIPK1 inhibitors and methods of uses thereof6 Oct 2026US 12,753,190 B2Merck Sharp & Dohme Corp.
- Urea, amide, and substituted heteroaryl compounds for CBL-B inhibition16 Jun 2026US 12,653,809 B2Nurix Therapeutics, Inc.
- Mitragynine analogs and uses thereof5 May 2026US 12,617,790 B2Memorial Sloan Kettering Cancer Center
- SMARCA inhibitors and uses thereof10 Mar 2026US 12,569,485 B2Kymera Therapeutics, Inc.
- Spirocyclic MDM2 modulator and uses thereof10 Mar 2026US 12,569,564 B2Newave Pharmaceutical Inc.
- Anti-inflammatory compounds, pharmaceutical compositions, and methods of treating hemochromatosis and other disorders8 Oct 2026US 2026/0308181 A1Miralogx LLC
- Kif18a inhibitor compound, and pharmaceutical composition and preparation method therefor and use thereof1 Oct 2026US 2026/0294927 A1Changchun Genescience Pharmaceutical Co., Ltd.
- Inhibitors of cyclin-dependent kinase (cdk) 12 and/or cdk13 and uses thereof1 Oct 2026US 2026/0297091 A1Insilico Medicine IP Limited
- Spirocyclic piperidine melanocortin subtype-2 receptor (mc2r) antagonists and uses thereof17 Sep 2026US 2026/0274848 A1Crinetics Pharmaceuticals, Inc.
- Nitrogenous heterocycles for organic electroluminescent devices17 Sep 2026US 2026/0282745 A1UDC Ireland Limited
Most cited
By later US patents
- Substituted tricyclic compounds as FGFR inhibitors44US 9,611,267 B2Incyte Corporation · 2017
- Discorhabdin compositions and their methods of use38US 4,731,366 AHarbor Branch Oceanographic Institution, Inc. · 1988
- Polycyclic carbamoylpyridone derivative having HIV integrase inhibitory activity38US 8,188,271 B2Shionogi & Co., Ltd. · 2012
- 8,9-anellated-1,2,3,4-tetrahydro-.beta.-carboline derivatives37US 5,328,905 ADuphar International Research B.V. · 1994
- Isoindolinone inhibitors of phosphatidylinositol 3-kinase37US 8,466,288 B2Vertex Pharmaceuticals Incorporated · 2013